Remarkably Fast and Easy to Use
Start operating the Spark with little to no training. Formulations are ready in seconds.
Plus, they can be made on-demand in a sterile hood for immediate cell culture application.
Explore Novel Genetic Medicine Formulations
Transformative medicines start with novel materials that can be costly or in limited supply. The Spark is ideal for screening novel genetic medicine formulations because it provides:
Advanced microfluidics allows microliter formulation volumes with near complete sample recovery.
Simply pipette starting materials into wells, push a button, and pipette completed formulations out.
The Spark formulation process requires less than 10 seconds, allowing hundreds of formulations to be made in hours.
Electronic control minimizes batch-to-batch and user variability.
The Spark system is designed for operation in a sterile biosafety hood, so formulations can be made on-demand, and applied to cells in culture.
NxGen micofluidic mixing technology allows formulations to be scaled across the NanoAssemblr Platform to accelerate future development.
Video
The NanoAssemblr® Spark™ uses proprietary microfluidics technology for the controlled and reproducible manufacturing of nanoparticles in small volumes in less than 10 seconds.
Cartridges & Kits
No cleaning or cleaning validation required: Cartridges are single-use and gamma irradiated for sterility. Available in packs of 20.
The GenVoy-ILM T Cell Kit for mRNA is an LNP reagent mix optimized for the delivery of mRNA into activated primary human T cells using mRNA-LNP.
Neuro9 kits contain everything you need to encapsulate siRNA into clinically validated lipid nanoparticle (LNP) delivery systems. Kits include a proprietary ionizable cationic lipid.